Treatment with Isoniazid for 9 Months is Required
This asymptomatic nurse with a 14 mm PPD requires treatment for latent tuberculosis infection (LTBI) with isoniazid for 9 months after ruling out active disease. None of the answer choices provided are optimal, but the closest appropriate management would involve isoniazid, not rifampin monotherapy.
Why This Nurse Needs Treatment
As a healthcare worker, this nurse falls into a high-risk category where a PPD of ≥10 mm is considered positive 1, 2. Healthcare workers with TB exposure are specifically identified as persons with increased probability of recent infection who warrant treatment regardless of age 1, 2.
The 14 mm induration clearly exceeds the 10 mm threshold for healthcare workers, making this a true positive test that requires intervention.
Initial Evaluation Required
Before starting treatment, you must:
- Obtain a chest radiograph to exclude active tuberculosis 3
- If any radiographic abnormalities suggesting old TB are present, obtain sputum samples for acid-fast bacilli 3
- Assess baseline liver function tests, particularly if the patient has risk factors for hepatic disease 2
Recommended Treatment Regimen
The standard treatment is isoniazid 300 mg daily for 9 months 1, 2. The guidelines clearly state this is the preferred regimen with an A(II) rating for both HIV-negative and HIV-positive patients 1.
Why 9 Months?
Prospective randomized trials demonstrate that while 12 months is more effective than 6 months, maximal benefit is achieved by 9 months 2. This balances efficacy with adherence concerns.
Why the Answer Choices Are Problematic
- Option A (No intervention): Incorrect - healthcare workers with positive PPD require treatment to prevent progression to active TB
- Options B & C (Rifampin monotherapy): While rifampin for 4 months is listed as an alternative regimen with B(II) rating 1, isoniazid for 9 months remains the gold standard. The 3-month and 6-month rifampin options listed are not standard recommendations
- Option D (4-drug therapy): This is for active TB disease, not LTBI
Alternative Regimens from Guidelines
If isoniazid cannot be used, the ATS/CDC guidelines 1 recommend:
- Rifampin daily for 4 months (B[II] rating)
- Rifampin-pyrazinamide for 2 months (though this has fallen out of favor due to hepatotoxicity concerns)
Monitoring During Treatment
- Clinical monitoring at monthly intervals for symptoms of hepatotoxicity (nausea, vomiting, abdominal pain, jaundice)
- Withhold isoniazid if transaminases exceed 3× upper limit of normal with symptoms or 5× upper limit if asymptomatic 2
- Routine laboratory monitoring is indicated for those with baseline abnormal liver function or other hepatic disease risk factors 2
Critical Pitfall to Avoid
Do not dismiss a 10-14 mm PPD reaction in healthcare workers as insignificant or attribute it solely to cross-reactivity 4. The guidelines are clear that healthcare workers with ≥10 mm induration should be treated as having LTBI after active disease is excluded.